CompletedPhase 3

Fish Oil and Cardiovascular Suboptimal Health

China422 participantsStarted 2014-09

Plain-language summary

The purpose of this study is to determine whether omega-3 fatty acids supplementation are effective in the improvement of suboptimal health status and cardiovascular risk.

Who can participate

Age range18 Years – 60 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. suboptimal health status, defined as the score of suboptimal health questionnaire ≥35.
✓. at least one of cardiovascular risk factors:
✓. written informed consent

Exclusion criteria

✕. history of system diseases, such as cardiovascular diseases, digestive system diseases, diseases of respiratory system, blood and immune system diseases, nervous system diseases, endocrine system diseases, and diseases of the genitourinary system.
✕. history of mental illness.
✕. pregnant or breastfeeding.
✕. use of antihypertensive, antidiabetic, or lipid-lowering drugs within the past two weeks.
✕. use of fish oil capsules or other supplements containing omega-3 fatty acids within the past two weeks.
✕. allergy or intolerance to fish oil, corn oil, omega-3 fatty acids, or vitamin E.
✕. participation in another trial.
✕. unable to promise to not use drugs and other fish oils during the study.

What they're measuring

the improvement of suboptimal health status

Timeframe: three months

the improvement of traditional cardiovascular risk factors

Timeframe: three months

Trial details

NCT IDNCT02103517

SponsorChinese PLA General Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2015-07

View on ClinicalTrials.gov More Suboptimal Health Status trials